Urinary Tract Infection Bacterial
12
2
2
6
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 42/100
8.3%
1 terminated out of 12 trials
85.7%
-0.8% vs benchmark
33%
4 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 6 completed trials
Clinical Trials (12)
Prediction and Prevention of Bloodstream Infections After Kidney Transplantation
Betadine vs Sterile Water for Periurethral Preparation
Relevance of the Urine Bacterial Culture Performed Before TransUrethral Resection of the Bladder for Post-operative Febrile Urinary Tract Infections Prevention: a Non-inferiority Randomized Controlled Trial
Comparison Between the Progostic Value of the Procalcitonin and the Platelet/Total Leukocytic Count Ratio in Sepsis
Dipsticks and Microscopy to Reduce Antibiotic Use in Women's Urinary Tract Infections: a Pilot Trial (MicUTI)
Evaluation of Urine Samples Obtained by Bladder Stimulation for the Diagnosis of Urinary Tract Infection in Infants
Expanded Access Program Using Uromune for Patients With Recurrent Urinary Tract Infections (rUTI)
Bacteriophage Therapy in Patients With Urinary Tract Infections
Shortened Antibiotic Treatment of 5 Days in Gram-negative Bacteremia
Evaluation of the Efficacy and Safety of MV140
Temocillin Versus Carbapenems for Urinary Tract Infection Due to ESBL-producing Enterobacteriaceae
Blood Parameters as a Predictor of Fever After Percutaneous Nephrolithotomy